Why does Abilify Maintena® have an FDA indication for bipolar disorder but Aristada® does not?

Question from a Member: Colleagues and I were having a discussion about the differences between Abilify Maintena® and Aristada®. The indication for Bipolar Disorder came up; Maintena has it, but Aristada does not, even though both convert to the same medication, at least in my oversimplified understanding. Is there a molecular/physiological reason for the difference…